Human Apolipoprotein C-III (Apo C3) AssayMax ELISA KitHuman Apolipoprotein C-III (Apo C3) AssayMax ELISA Kit
Move your mouse over image or click to enlarge

Human Apolipoprotein C-III (Apo C3) AssayMax ELISA Kit

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.

Cat# Size Price Qty Buy
EA8133-1 96 Well Plate £276.25

Additional Information

Property Value or Rating
Manufacturer Assaypro, LLC.
Product Type AssayMax™ ELISA Kits
Samples Serum, Urine, Milk, Cell Culture, CSF
Species Human
Reactivity Human
Assay Format Sandwich ELISA
Product Size 96 Well Plate
Range 1.95 - 500 ng/ml
Plex Number 1
Storage Refer to component labels for details
Entrez Gene 345
Omim 107720
UniProt P02656
UniGene Hs.73849
Special Notes For Research Use Only, Not To Be Used For Diagnostic Purposes
References * Hansen JB et al. (2011) The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis. J Lipids. 2011:271062 doi:10.1155/2011/271062 
* Papakostas GI (2011) Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study. Molecular Psychiatry doi:10.1038/mp.2011.166 
* Wang Y et al. (2011) Development of a Sensitive ELISA to Quantify Apolipoprotein CIII in Non-human Primate Serum. J Lipid Res. 52(6):1265-1271 
* Hyysalo J (2012) Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2012 May;27(5):951-956 
* Pi B et al. (2012) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application number: US20120178118 A1 
* Sakamoto H et al. (2012) An Apolipoprotein CIII-Derived Peptide, Hatktak, Activates Macromolecular Activators of Phagocytosis from Platelets (MAPPs). Lipoproteins - Role in Health and Diseases. Chapter 31. p.721-740 
* Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1 
* Lee J et al. (2013) Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response. Am J Reprod Immunol. 2013 Oct;70(4):265-84. doi: 10.1111/aji.12142. Epub 2013 Jul 30 
* Nichols SKF et al. (2013) Impaired lipid transport in gestational diabetes mellitus. Journal of Diabetes Research & Clinical Metabolism. doi: 10.724/2050-0866-2-22 
* Pi B and Bilello J (2013) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application EP20110846638 
* Riwanto M et al. (2013) Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation. 127(8):891-904 
* Richard C et al. (2014) Effect of Mediterranean Diet With and Without Weight Loss on Apolipoprotein B100 Metabolism in Men With Metabolic Syndrome. Arterioscler Thromb Vasc Biol. 34:433-438 
* Bridge SH et al.(2015) PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism. J Hepatol. 2015 Apr;62(4):763-70. Epub 2014 Nov 21 
* Sandin A et al. (2015) QUANTITATIVE DETERMINATION OF PROTEIN APOCIII IN SERUM: COMPARISON OFTHREE ASSAY METHODS. Clin. Chem Lab Med 2015:53, Special Suppl, pp S248 
* Hyysalo J (2017) PREVALENCE AND GENETICS OF NON-ALCOHOLIC FATTY LIVER DISEASE. University of Helsinki.

" title="

* Hansen JB et al. (2011) The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis. J Lipids. 2011:271062 doi:10.1155/2011/271062 
* Papakostas GI (2011) Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study. Molecular Psychiatry doi:10.1038/mp.2011.166 
* Wang Y et al. (2011) Development of a Sensitive ELISA to Quantify Apolipoprotein CIII in Non-human Primate Serum. J Lipid Res. 52(6):1265-1271 
* Hyysalo J (2012) Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2012 May;27(5):951-956 
* Pi B et al. (2012) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application number: US20120178118 A1 
* Sakamoto H et al. (2012) An Apolipoprotein CIII-Derived Peptide, Hatktak, Activates Macromolecular Activators of Phagocytosis from Platelets (MAPPs). Lipoproteins - Role in Health and Diseases. Chapter 31. p.721-740 
* Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1 
* Lee J et al. (2013) Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response. Am J Reprod Immunol. 2013 Oct;70(4):265-84. doi: 10.1111/aji.12142. Epub 2013 Jul 30 
* Nichols SKF et al. (2013) Impaired lipid transport in gestational diabetes mellitus. Journal of Diabetes Research & Clinical Metabolism. doi: 10.724/2050-0866-2-22 
* Pi B and Bilello J (2013) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application EP20110846638 
* Riwanto M et al. (2013) Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation. 127(8):891-904 
* Richard C et al. (2014) Effect of Mediterranean Diet With and Without Weight Loss on Apolipoprotein B100 Metabolism in Men With Metabolic Syndrome. Arterioscler Thromb Vasc Biol. 34:433-438 
* Bridge SH et al.(2015) PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism. J Hepatol. 2015 Apr;62(4):763-70. Epub 2014 Nov 21 
* Sandin A et al. (2015) QUANTITATIVE DETERMINATION OF PROTEIN APOCIII IN SERUM: COMPARISON OFTHREE ASSAY METHODS. Clin. Chem Lab Med 2015:53, Special Suppl, pp S248 
* Hyysalo J (2017) PREVALENCE AND GENETICS OF NON-ALCOHOLIC FATTY LIVER DISEASE. University of Helsinki.

" target="_blank">

* Hansen JB et al. (2011) The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis. J Lipids. 2011:271062 doi:10.1155/2011/271062 
* Papakostas GI (2011) Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study. Molecular Psychiatry doi:10.1038/mp.2011.166 
* Wang Y et al. (2011) Development of a Sensitive ELISA to Quantify Apolipoprotein CIII in Non-human Primate Serum. J Lipid Res. 52(6):1265-1271 
* Hyysalo J (2012) Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2012 May;27(5):951-956 
* Pi B et al. (2012) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application number: US20120178118 A1 
* Sakamoto H et al. (2012) An Apolipoprotein CIII-Derived Peptide, Hatktak, Activates Macromolecular Activators of Phagocytosis from Platelets (MAPPs). Lipoproteins - Role in Health and Diseases. Chapter 31. p.721-740 
* Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1 
* Lee J et al. (2013) Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response. Am J Reprod Immunol. 2013 Oct;70(4):265-84. doi: 10.1111/aji.12142. Epub 2013 Jul 30 
* Nichols SKF et al. (2013) Impaired lipid transport in gestational diabetes mellitus. Journal of Diabetes Research & Clinical Metabolism. doi: 10.724/2050-0866-2-22 
* Pi B and Bilello J (2013) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application EP20110846638 
* Riwanto M et al. (2013) Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation. 127(8):891-904 
* Richard C et al. (2014) Effect of Mediterranean Diet With and Without Weight Loss on Apolipoprotein B100 Metabolism in Men With Metabolic Syndrome. Arterioscler Thromb Vasc Biol. 34:433-438 
* Bridge SH et al.(2015) PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism. J Hepatol. 2015 Apr;62(4):763-70. Epub 2014 Nov 21 
* Sandin A et al. (2015) QUANTITATIVE DETERMINATION OF PROTEIN APOCIII IN SERUM: COMPARISON OFTHREE ASSAY METHODS. Clin. Chem Lab Med 2015:53, Special Suppl, pp S248 
* Hyysalo J (2017) PREVALENCE AND GENETICS OF NON-ALCOHOLIC FATTY LIVER DISEASE. University of Helsinki.

Related Documents